Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

In situ tumor arrays reveal early environmental control of cancer immunity [STAMP D8]

ABSTRACT: KPP-GFP (C57Bl/6) cells were implanted into the laser-induced micropores ears of B6.Cg-Foxn1nu/J (C57Bl/6J Jackson background) that were adoptively transferred with 4x10^6 naive CD4tdTomato-positive Tcells (B6 N/J background) the same day. The STAMP microtumors were imaged daily starting at day 3 after tumor cell implantation. On day 8 after tumor cell implantation tumors were classified as either (1) Inflamed, (2) Excluded, (3) Ignored/Desert or (4) Resolved.

ORGANISM(S): Mus musculus

PROVIDER: GSE222027 | GEO | 2023/02/17

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Array analysis of wound induced hair neogenesis (early stage)

Project description:Mice were wounded and skin samples of the scar collected on the day of wound closure. We compared Mixed mice (B6/FVB/SJL), a strain of high regeneration, versus C57bl mice, a strain of low regeneration.

2015-08-05 | GSE50418 | GEO

Expression data from liver of male mouse at 10-week-old

Project description:To investigate mouse intersubspecific divergence of transcriptional regulation between C57BL/6J (B6) and Japanese wild-derived MSM/Ms strains, we performed transcriptome analysis by microarray on liver from B6 and MSM, and B6-ChrNMSM chromosome substitution strain panel, which carries MSM-derived chromosome or chromosomal segment on the B6 host.

2023-03-31 | GSE72825 | GEO

Gene expression data from teratomas formed by C57BL/6 (B6) ES and EiPS cells in B6 mice

Project description:Embryonic fibroblast from C57BL/6 (B6) mice were reprogrammed to EiPS without exogenous DNA integration using an single episomal vector. The EiPS cells and B6 ES cells were then transplanted into B6 mice to form teratomas. We used microarrays to profile the gene expression differences between the teratomas formed by B6 ES cells and EiPS cells.

2011-04-13 | GSE28573 | GEO

Phosphoproteomics of mouse cardiomyocytes reveals signalling pathways triggered by a vasodilator cryptide

Project description:Animal venoms are natural sources of bioactive molecules such as cryptides that consist in biological active peptides released after proteolytic cleavage of a peptide or protein precursor. The KPP is a cryptided derived from the c-terminal of an hypotensin (TsHpI) a peptide isolated from the venom of Tityus serrulatus scorpion. Previous studies of our group in rodent model demonstrated that KPP maintained the cardioprotective properties of its precursor. Nonetheless, the molecular machinery involved in the cellular response is poorly described to date. Thus, in order to characterize the signalling pathways triggered by KPP we incubate mouse cardiomyocytes with KPP during 5 or 30 min and explore the cell proteome and phosphoproteome by dimethyl labelling quantitation.

2020-07-06 | PXD015068 | Pride

Fine Time-Course Expression Analysis of Mammalian Sex Determination in 129S1/SvImJ and C57BL/6J XX and XY mice

Project description:We analyzed the differentiation of the bipotential gonad into a testis or an ovary in 2 strains of mice - 129S1/SvImJ (129S1) and C57BL/6J (B6). Our results provide a high resolution view of the initiation and canalization of the differentiation of the gonad. It also reveals global differences in the transcriptome between 129S1 and B6 mice. Total RNA was obtained from XX and XY embryonic mouse gonads at 6 equally spaced time points between embryonic day (E) 11.0 and E12.0 from 129S1 and B6 mice. Mice were staged using tail somite numbers

2013-06-11 | E-GEOD-41948 | biostudies-arrayexpress

Identification of a cryptic MHC-E epitope from influenza virus

Project description:B6-CIITA-E cell line (C57Bl/6 fibroblasts expressing MHC-II molecules I-Ab and I-Ed) was infected with Influenza A virus (A/Puerto Rico/8/1934, PR8) or left uninfected (control), and the MHC-class II-associated peptidome analysed via immunopeptidomics.

2023-10-10 | PXD045025 | Pride

nCounter Mouse Inflammation (V2) Panel on Muscle from Cancer Cachexia Models

Project description:Mice were eithier injected with LLC or C26 cells, or injected with tamoxifen to indcue pancratic cancer in the KPP model. Matched controls were injected with PBS to mimic cell injections and control mice were injected with tamoxifen as controls for KPP.

2024-08-01 | GSE245208 | GEO

Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis - T-cell tracing supernatants

Project description:C57BL/6 mice were orthotopically implanted with PK5L1940 cells. 8 Gy RT was administered 7 days post-implantation. PD1-IL2v and aCD25 dosed once per week beginning day 7 post-implantation. Spleens and lymph nodes were harvested 17 days post implantation and the sorted T-cells cultured in the presence of 13C6 glucose for 6h. This study contains longitudinal sampling of the cell culture supernatants.

2023-02-21 | ST002488 | MetabolomicsWorkbench

Modeling Human Cancer-induced Cachexia (Mouse)

Project description:Cachexia is a wasting syndrome characterized by pronounced skeletal muscle loss. In cancer, cachexia associates with increased morbidity and mortality and decreased treatment tolerance. Although advances have been made in understanding the mechanisms of cachexia, translating these advances to the clinic has been challenging. One reason for this shortcoming may be the current animal models that fail to fully recapitulate the etiology of human cancer-induced tissue wasting. Because pancreatic ductal adenocarcinoma (PDA) presents with a high incidence of cachexia, we engineered a mouse model of PDA, that we named KPP. KPP mice, similar to PDA patients, progressively lose skeletal and adipose mass as a consequence of their tumors. In addition, KPP muscles exhibit a similar gene ontology to cachectic patients. We envision the KPP model will be a useful resource for advancing our mechanistic understanding and ability to treat cancer cachexia.

2019-08-06 | GSE133524 | GEO

Modeling Human Cancer-induced Cachexia (Human)

2019-08-06 | GSE133523 | GEO